AR057409A1 - Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. - Google Patents

Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.

Info

Publication number
AR057409A1
AR057409A1 ARP060102752A ARP060102752A AR057409A1 AR 057409 A1 AR057409 A1 AR 057409A1 AR P060102752 A ARP060102752 A AR P060102752A AR P060102752 A ARP060102752 A AR P060102752A AR 057409 A1 AR057409 A1 AR 057409A1
Authority
AR
Argentina
Prior art keywords
nrcrd
alkyl
alkenyl
atom
alkynyl
Prior art date
Application number
ARP060102752A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Bothe
Ulrike Fuhrmann
Carsten Moller
Norbert Schmees
Anja Schmidt
Wolfgang Schwede
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of AR057409A1 publication Critical patent/AR057409A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
ARP060102752A 2005-06-24 2006-06-27 Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas. AR057409A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
AR057409A1 true AR057409A1 (es) 2007-12-05

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060102752A AR057409A1 (es) 2005-06-24 2006-06-27 Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.

Country Status (22)

Country Link
EP (1) EP1899315A1 (ru)
JP (1) JP2008543911A (ru)
KR (1) KR20080018275A (ru)
CN (1) CN101248056A (ru)
AR (1) AR057409A1 (ru)
AU (1) AU2006261049A1 (ru)
BR (1) BRPI0612305A2 (ru)
CA (1) CA2611900A1 (ru)
CR (1) CR9595A (ru)
DE (1) DE102005030294A1 (ru)
DO (1) DOP2006000150A (ru)
EA (1) EA200702604A1 (ru)
EC (1) ECSP078043A (ru)
GT (1) GT200600272A (ru)
IL (1) IL188022A0 (ru)
MX (1) MX2008000070A (ru)
NO (1) NO20080441L (ru)
PE (1) PE20070170A1 (ru)
TW (1) TW200738665A (ru)
UY (1) UY29626A1 (ru)
WO (1) WO2006136462A1 (ru)
ZA (1) ZA200800689B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
WO2014070517A1 (en) 2012-11-02 2014-05-08 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods
DE60309829T2 (de) * 2002-01-14 2007-09-13 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
PL372490A1 (en) * 2002-03-11 2005-07-25 Schering Aktiengesellschaft 5-{2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino}-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replacement therapy
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
GT200600272A (es) 2007-08-20
CN101248056A (zh) 2008-08-20
TW200738665A (en) 2007-10-16
DOP2006000150A (es) 2006-12-31
NO20080441L (no) 2008-03-07
EP1899315A1 (en) 2008-03-19
BRPI0612305A2 (pt) 2010-11-03
EA200702604A1 (ru) 2008-06-30
KR20080018275A (ko) 2008-02-27
CR9595A (es) 2008-05-05
JP2008543911A (ja) 2008-12-04
WO2006136462A1 (en) 2006-12-28
MX2008000070A (es) 2008-03-19
IL188022A0 (en) 2008-03-20
UY29626A1 (es) 2007-01-31
AU2006261049A1 (en) 2006-12-28
ECSP078043A (es) 2008-01-23
PE20070170A1 (es) 2007-03-02
ZA200800689B (en) 2009-07-29
CA2611900A1 (en) 2006-12-28
DE102005030294A1 (de) 2007-01-04

Similar Documents

Publication Publication Date Title
AR057409A1 (es) Heterociclos oxigenados como moduladores de receptores de progesterona. composiciones farmaceuticas.
PE20211795A1 (es) Compuestos heteroaril tetraciclicos
AR030306A1 (es) Derivados de piperazina, un procedimiento para su preparacion, composiciones farmaceuticas, un metodo para su fabricacion y el uso de dichos derivados para la fabricacion de un medicamento
AR082985A1 (es) INHIBIDORES DE PI3K-d Y METODOS DE SU USO Y PREPARACION
AR035305A1 (es) Derivados y analogos del acido 3-arilpropionico, proceso para su preparacion, formulaciones farmaceuticas, uso de los mismos en la elaboracion de medicamentos, y formulacion farmaceutica para usar en la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina
CO6210771A2 (es) Moduladores 2-aminopirimidina del receptor de histamina h4
AR078756A1 (es) Moduladores alostericos positivos (map)
AR035518A1 (es) Derivados de carboxamida, un procedimiento para su preparacion, un medicamento que los contiene, el u so de los mismos para preparar un medicamento, y un conjunto (kit) que los incluye
AR064547A1 (es) Derivados de azaspiro como antagonistas del receptor v1a
PA8604201A1 (es) Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades
AR081859A1 (es) Pirimidinas 2,4,6-trisustituidas, composiciones farmaceuticas que las comprenden y su uso en el tratamiento de tumores sensibles a la inhibicion de la cinasa atr
BR112014029868A2 (pt) compostos, e, composição farmacêutica
BRPI1011649A2 (pt) compostos tetracíclicos e composição farmacêutica que os compreende
AR082667A1 (es) 6-cicloalquil-pirazolopirimidinonas para el tratamiento de trastornos del snc
PA8517101A1 (es) Derivados de tropano ùtiles en terapia
ECSP088293A (es) Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado
BR112015032637A2 (pt) derivados de pirrolopiridina ou pirazolopiridina
AR059328A1 (es) Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp
AR054863A1 (es) DERIVADOS DE 1H-PIRROLO[3, 4-C]PIRAZOL, UN PROCESO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES ASOCIADAS CON EL FACTOR DE COAGULACIoN XA
AR054208A1 (es) Derivados de oxopiperidina, su preparacion, una composicion farmaceutica y compuestos intermediarios
AR074352A1 (es) Acidos naftalen-2-il-aceticos sustituidos, composiciones farmaceuticas que los contienen, y uso de los mismos en el tratamiento de enfermedades alergicas,tales como rinitis, asma y dermatitis atopica.
AR067075A1 (es) Derivados de isoxasol - imidazol
UY29802A1 (es) Análogos de la feniletilamina y su uso en el tratamiento del glaucoma
ES2909874T3 (es) Retinoides sintéticos fluorescentes
CO2019002673A2 (es) Derivados de cromano, isocromano y dihidroisobenzofuranos como moduladores alostéricos negativos de mglur2, composiciones y su uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure